Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

CT-P59

- PMLiVE

Lilly and AbCellera partner on antibody therapies for COVID-19

Latest companies to join the fight against the novel coronavirus

Roche Basel Switzerland

FDA okays Roche’s COVID-19 diagnostic test

Increases capacity for testing as coronavirus cases grow

- PMLiVE

UK officially moves into ‘delay’ phase of coronavirus plan

New measures includes broader self-isolation advice

- PMLiVE

WHO labels coronavirus outbreak a pandemic as cases spread globally

WHO director-general maintains countries can still "change the course" of the outbreak

- PMLiVE

Chancellor’s ‘coronavirus budget’ also pledges big R&D gains

Includes measures to help businesses disrupted by the pandemic

- PMLiVE

Gates Foundation, Wellcome launch fast-track COVID-19 therapy fund

Partners commit $125m to seed-fund for potential treatments

- PMLiVE

NHS increases COVID-19 testing capacity, FDA halts foreign inspections

New measures to tackle the novel coronavirus announced across the Atlantic

EU flag

EMA to consider coronavirus’ impact on EU medicines supply

Steering group will identify EU-wide actions to mitigate medicine supply risks

Gamer

Could coronavirus turn us all into online gamers?

As businesses gauge the potential impact of coronavirus (COVID-19), with a sense of fear and pessimism causing a dampening of economic activity and suspension of the stock market, the healthcare...

Page & Page and Partners

- PMLiVE

US Department of Health and Human Services calls for coronavirus product proposals

Move will fast-track the development of potential treatments

- PMLiVE

UK government considers move into ‘delay’ phase of coronavirus response plan

Proposed emergency measures could include 'social distancing'

- PMLiVE

Takeda begins development of COVID-19 plasma therapy

Drug will harness the antibodies of recovered coronavirus patients

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links